Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms
Top Cited Papers
- 21 May 2007
- journal article
- Published by Elsevier in Human Pathology
- Vol. 38 (9) , 1361-1371
- https://doi.org/10.1016/j.humpath.2007.01.028
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Current Status and Future ApplicationsSeminars in Oncology, 2006
- Erratum: Frequent hyperphosphorylation of ribosomal protein S6 in lymphangioleiomyomatosis-associated angiomyolipomasLaboratory Investigation, 2006
- Frequent of ribosomal protein S6 hyperphosphorylation in lymphangioleiomyomatosis-associated angiomyolipomasLaboratory Investigation, 2006
- The Role of Tuberin in Cellular Differentiation: Are B‐Raf and MAPK Involved?Annals of the New York Academy of Sciences, 2005
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- Efficacy of a rapamycin analog (CCI‐779) and IFN‐γ in tuberous sclerosis mouse modelsGenes, Chromosomes and Cancer, 2004
- TOR SignalingScience's STKE, 2003
- Integration of Growth Factor and Nutrient SignalingMolecular Cell, 2003
- The Tuberin-Hamartin Complex Negatively Regulates β-Catenin Signaling ActivityJournal of Biological Chemistry, 2003
- High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis ComplexMayo Clinic Proceedings, 2000